// App-Quantinova.ai

OA0185 : YKL‐40 As biomarker in severe asthma

Researchers

Presenter

  • E Castro MC

Principal Investigators

  • Lockett GA

  • Lau LC

  • Barber C

  • Scott E

  • Brown T

  • Chauhan A

  • Holloway JW

  • Howarth PH

Medical Centers

  • CHLN‐HSM‐ ImmunoAllergy, Lisbon, Portugal

  • Lisbon Medical School‐ Universidade de Lisboa, Lisbon, Portugal

  • Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  • Academic Unit of Cancer Sciences Faculty of Medicine, University of Southampton,Southampton, United Kingdom

  • Portsmouth Hospital NHS Trust, Portsmouth, United Kingdom

  • Southampton NIHR Biomedical Research Centre, Southampton, United Kingdom

Locations

  • Portugal

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved